Prenatal Transplantation for Fetuses With Fanconi Anemia (NCT07408583)
A Phase I/II, Non-Randomized Study of the Safety and Efficacy of In Utero Hematopoietic Stem Cell Transplantation for the Treatment of Fanconi Anemia in Affected Fetuses
🩺 Plain-English Summary (8th-Grade Level)
The investigators aim to evaluate the safety and efficacy of in utero hematopoietic stem cell transplantation (IUHSCT) for the treatment of fetuses diagnosed with Fanconi anemia (FA) during pregnancy.
Who can join: Review the eligibility criteria below.
Location: University of California, San Francisco — San Francisco, California
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- University of California, San Francisco — San Francisco, California
- Stanford University — Stanford, California
📞 Contact the Study Coordinator
Phone: (650) 497-2218
Email: bmf@stanfordchildrens.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Fanconi Anemia
- Eltrombopag for People With Fanconi Anemia — Bethesda, Maryland
- MRI as Noninvasive Innovative Approach in Detection and Monitoring of Malignant Oral Lesions in Fanconi Anemia Patients — Minneapolis, Minnesota
- HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy — New York, New York
- Depleted Donor Stem Cell Transplant in Children and Adults With Fanconi Anemia After Being Conditioned With a Regimen Containing Briquilimab — Stanford, California
- Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders — Minneapolis, Minnesota
Explore by condition: All Fanconi Anemia clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.